view fairli unev quarter result
less expect ep in-lin organ sale growth
remain weak anticip though consum beauti
weaker thought luxuri stronger
also announc sell youniqu back
founder sale ebit margin
huge surpris direct sell busi never quit fit
run separ expect proce far less
paid stake littl year ago estimate
guidanc impli modest improv
hard see upsid guidanc given on-going challeng
consum beauti addit guidanc back-end weight
oper profit growth expect moder
due higher spend despit easiest top-lin comparison
year overal commend new management team bring
stabil busi last two quarter howev see
 catalyst think top-lin inflection/acceler
necessari move stock higher expect top-lin
growth remain weak part due coti structur
disadvantag portfolio unlik chang
maintain market perform rate lower price target
due back-half weigh outlook
consum beauti slow consum beauti organ
sale growth slow vs underli basi
driven tougher y/i comparison slow-down youniqu
management expect organ sale declin moder vs
driven signific ramp spend
moder shelf space loss though wont lap headwind
sale youniqu
drag total compani organ sale growth impli
drag consum beauti management expect see
posit signal seen littl evid
improv track channel date overal remain
cautiou outlook consum beauti estimate organ
sale
ep in-lin clean report adj ep
y/i in-lin our/consensu estimate ebit
ahead estimate sg below-the-lin item
combin in-lin result takeaway includ
organ sale growth roughli in-lin consensu
ebit margin y/i
estimate free solid y/i
guidanc unchang organ sale growth stabl slightli lower
adj ebit ex fx ep msd moder
improv lower ep estimate
maintain ep est
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
compani data secur llc estim reuter
report ep in-lin consensu report adjust ep
y/i in-lin our/consensu estim overal ebit ahead
estim sg below-the-lin item drag tax expens combin
in-lin result vs forecast
organ sale growth remain weak organ sale growth roughli in-lin
consensu better estim reflect slowdown vs
organ sale growth seen underli basi driven acceler declin consum
beauti profession beauti result segment
luxuri organ sale growth well ahead estim saw
strong growth almea travel retail particularli china growth
brand report growth burberri calvin klein hugo boss marc jacob gucci
also saw growth part recent relaunch gucci make-up organ growth
improv vs ex temporari factor
consum beauti organ sale estim
sale growth slow vs organ sale
profession beauti organ growth in-lin estim
weak result driven inventori destock north america follow suppli
chain issu partial offset dd growth ghd driven innov
organ sale growth slow vs declin
consum beauti result deceler organ sale growth consum beauti
slow sequenti vs exclud temporari factor
slowdown driven tougher y/i comparison vs sell-in ahead suppli chain chang
year ago period deceler result youniqu adjust oper incom y/i
signific improv vs balanc profit materi
consum beauti result remain pressur on-going weak mass channel
europ includ shelf space declin addit on-going pressur youniqu partial
off-set posit growth brazil bodi care brand color cosmet hair sale remain
weak low-teen -hsd respect note track
channel sale remain among worst hpc repres consum beauti sale
total compani sale sale week end vs
per nielsen
look forward expect consum beauti organ sale growth remain pressur due
shelf space loss cover girl clairol rimmel categori headwind
europ on-going shelf space loss stem spring reset
sell youniqu back founder announc sell stake youniqu
back founder detail disclos estim proce far less
paid busi feb youniqu direct seller never quit fit
coti busi model run separ sale profit recent
sever pressur estim youniqu sale compar
bought busi addit youniqu gener oper
incom impli ebit margin well ebitda margin
busi post like minim given size profit brand
dont expect materi impact coti result despit realiz signific loss
sharehold valu associ transact believ decis divest busi
right one youniqu prioriti go forward sell brand allow
manag focu exclus execut turnaround plan
oper margin slightli expect driven sg gross margin
y/i driven part mix shift toward higher-margin luxuri segment
estim meanwhil sg y/i expect
collect ebit margin y/i estim
free improv materi free cash flow
y/i manag improv impress y/i
manag expect report moder improv estim
guidanc unchang guidanc call organ sale growth stabl slightli
lower oper incom ex fx ep msd moder improv
note guidanc impli on-going organ sale weak despit face easi
comparison vs suppli chain issu
compani trend pictur
chart compani report secur llc estim
growth margin net sale rh chang gross margin bp lh y/i chang bp net margin net sale rh chang oper margin bp lh y/i chang bp net incom growth y/i chang y/i chang y/i chang y/i chang rh ep growth y/i chang growth margin net sale rh chang oper margin bp lh y/i chang bp net sale inc
compani trend pictur cont
chart compani report secur llc estim
ebit margin vs
vs
net debt/ebitda less vs current
manag unveil long-await turnaround plan plan build ceo laubi core
busi principl includ better bigger busi focu qualiti busi
grow market share cost manag gross margin obsess view
lifeblood busi select scale brand build manag take highli
disciplin approach vs experiment cultur
ambiti target laid overal view manag target ambiti
organ sale improv flat net revenu stabl ex fx
believ ebit margin target appear aggress manag call
expans time increas advertis spend materi move
closer peer level upper move sale
manag expect fund increas invest via gross margin improv
fix cost reduct particular manag see gross margin gap vs peer expect
close gap next four year ebit margin estim remain
manag target rang believ level gross margin improv could less
top-lin outlook highlight portfolio challeng organ growth expect improv
flat net revenu similar absolut basi ex fx
manag note current market growth category/countri compar
coti organ sale growth impli under-perform gap manag outlin
sever key initi improv organ sale growth includ focus invest behind top
growth margin net sale rh chang oper margin bp lh y/i chang bp net growth margin net sale rh chang oper margin bp lh y/i chang bp net sale cosmet household person
country/brand combin repres net revenu take data-bas approach
optim assort includ signific sku reduct note coti sku
margin dilut step-chang dd increas next year sale
said given mix channel countri even abl hold
share compani would remain growth disadvantag vs faster grow beauti peer
expos higher growth channel prestig beauti countri asia pacif
portfolio composit evolut revolut next year
manag focus evolv busi organ expand exist brand new
market leverag exist infrastructur manag aspir evolv portfolio
time toward higher growth area howev believ limit given coti high leverag
like mean drastic portfolio chang unlik near-term
announc new organiz structur effort streamlin decis make reduc
fix cost chang organiz structur effect split commerci
market respons luxuri consum beauti busi new region commerci
team split europ middl east africa emea america
asia pacif brand market unit luxuri consum beauti run separ profession
beauti remain separ busi unit given uniqu distribut channel salon addit
move headquart amsterdam execut team corpor function
locat manag expect improv speed effici
new restructur announc order fund new turnaround plan manag expect
incur increment spend top remain
cost prior restructur plan new cost relat organiz chang
includ hq chang expect gener increment annual save
remain cost relat turnaround plan includ suppli chain simplif
de-lever focu conjunct earn manag gave clear indic
de-lever key prioriti introduc net debt/ebitda target vs current
introduc dividend elect program go forward investor choos elect
receiv quarterli dividend split cash stock jab owner
coti share elect take stock/cash option leverag target reach
allow alloc increment cash annual toward de-lever jab alon
overal view plan posit give addit flexibl de-lever reduc
investor concern risk dividend cut plan result modest share issuanc
headwind ep jab portion view reason trade-off addit cash
jab rais stake addit purchas limit
due revers morri trust structur pg beauti transact largest sharehold
jab limit abil buy back issu share two-year without trigger tax
expir lift jab acquir share stock via tender
offer tender offer jab rais stake prior stake tender
offer accomplish number key object jab perspect send strong signal jab
long-term commit bring jab back major ownership key object jab
allow maintain public float long-term sharehold particip futur upsid
maintain option road
review tender offer special committe coti independ board member enter
stockhold agreement jab accord agreement jab subject ownership cap
outstand share three year complet tender offer
expect jab continu purchas share time could help limit downsid risk share
howev ownership cap place jab limit abil buy share
next year
inc financi guidanc secur llcjoe lachki except per-shar data sourc tabl compani report secur llc estimatespg beauti save end capit end capit save programgross savingsup yearsnet yearsrestructur restructuringgross provid juli call fy sale itemsnet revenuesst vs oper provid juli call august call fy fy sale growthmoder declinest slightli oper ep flowmoder improvementmoder provid august call novemb call februari call may call fy sale growthflat modest growthimprov oper profit mid-teensgrowthmoder ex fxmoder ex oper marginwel itemspg ratelow guidanc save sfi guidancefi guidanc cosmet household person
reiter market perform rate inc price target
lead manufactur beauti product fragranc hair color retail profession
channel color cosmet skin bodi categori compani built via
greatli expand scale octob pg beauti acquisit pg beauti deal immedi
creat scale multipl key categories/countri provid platform increment transform
 long term said result sinc pg acquisit challeng given
under-perform acquir asset along execut issu relat combin
addit believ coti current portfolio remain structur disadvantag vs peer expos
slower grow countri channel
next year expect top-lin organ growth improv low singl digit margin
expans driven product save synergi de-lever drive msd hsd ep
growth ex currenc believ product save synergi pg beauti deal
transform plan like achiev howev fundament weak particularli
top-lin near-term macro-environ remain neg categori weak plu heighten
competit environ littl visibl consist posit top-lin growth result
like choppi addit brand turnaround cover girl clairol new
organiz structur increas near-term execut risk expect continu pursu
smaller accret bolt-on acquisit current high leverag cash flow challeng like take
transform tabl manag medium-term leverag target achiev
overal see substanti cost save ahead plu option littl near-term
visibl remain concern on-going categori pressur europ mass beauti
continu look evid acceler sell-through/market share trend improv categori
growth evid margin cash flow improv becom construct
price target base price-to-earnings ev/ebitda multipl appli
estim multipl repres discount current hpc multipl believ
on-going execut risk brand restag integr turnaround plan
inc earn varianc sheet secur llcjoe lachki except per-shar data compani report secur llc estimatesfisc year end june earningsreport diff gener expens expense/ incom pre-tax incom eps- bp consolid marginsgross ebit bp like-for-lik sale sale vs estimateyear/year changesequenti changeyear/year changediff bp actual vs estimateyear/year changesequenti changeyear/year changeactu vs estimateyear/year changesequenti changeyear/year cosmet household person
compani report secur llc estim
inc quarterli revenu build dollar million except per share net compani foreign foreign beauti foreign beauti foreign year stack period net inc
compani report secur llc estim
inc quarterli incom statement dollar million except per share sales- sales- profit- profit- margin- margin chang gener administrative- yr/yr other- impair sale income- income- margin- margin chang margin- expens net- expense/ incom net- other- exp /other income- income- margin- incom taxes- incom taxes- rate- rate- income- attribut non-controlling erests- attribut non-controlling erests- incom attribut inc incom attribut inc continu operationsdilut eps- eps- outstand percentag changenet gener cosmet household person
estim nielsen track channel data repres coti total net sale
volum average price/unit growth
dollar share y/i chang
chart nielsen xaoc includ c-store secur llc
note nielsen quarter-to-d data repres simpl averag nielsen data period follow last period
nielsen xaoc includ c-store secur llc estim
sale y/yeq sale y/yavg eq price y/i sold promo sold promo y/ydollar sharedollar share y/i bp retailperiod end end end end end end end shave polish channel data chang bp dollar quarterli consum beauti organ sale performanceconsum take-away retail vs manufactur shipment report nielsenreported/estimatedcorrel inc
price target
price target base price-to-earnings ev/ebitda multipl estim
multipl reflect discount current hpc averag driven recent weak top-lin trend
limit visibl risk execut relat integr pg beauti acquisit brand
restag poor mass beauti market trend increas competit particularli develop
market well strength dollar
see substanti cost save ahead driven manag transform howev weak
underli fundament perform execut issu littl near-term visibl leav us sidelin
inc base new york ny lead manufactur beauti product fragranc
color cosmet skin bodi hair color categori deep portfolio own
rimmel salli hansen clairol adida wella product sold countri
territori key distribut channel mass ultra-prestig three busi segment
luxuri consum beauti profession beauti
